AIM
AXSM icon

Axiom Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Axiom Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,000
Closed -$413K – 120
2019
Q4 		$413K Buy
+4,000
New +$162K 0.59% 55
2019
Q3 		– Sell
-8,000
Closed -$206K – 230
2019
Q2 		$206K Buy
+8,000
New +$160K 0.04% 351

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Axiom Investment Management's AXSM Position: Q1 2020 in Review

Axiom Investment Management sold out of Axsome Therapeutics (AXSM) in Q1 2020, closing a stake of 4,000 shares — an estimated $413K sold.

Axiom Investment Management first reported a position in AXSM in Q2 2019 and held it in 2 quarters. The position peaked at $413K in Q4 2019. 163 funds tracked by Wall St. Rank hold AXSM as of Q1 2020.

  • Axiom Investment Management reported no remaining Axsome Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Axiom Investment Management sold 4,000 Axsome Therapeutics shares in Q1 2020, an estimated $413K.
  • Axiom Investment Management first reported a position in Axsome Therapeutics in Q2 2019 and held it in 2 quarters.
  • Axiom Investment Management's Axsome Therapeutics position peaked at $413K in Q4 2019.
  • 163 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2020.

Based on Axiom Investment Management's 13F filing for Q1 2020, filed 16 Mar 2021.